3M vs Stryker stock
Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.
3M is more profitable, is cheaper for its profits and has less debt. Stryker grows faster.
Side by side
| 3M | Stryker | |
|---|---|---|
| $94.9 billion | $118 billion | |
| 13.0% | 12.9% | |
| −5.0% | +11.8% | |
| 29.2× | 36.3× | |
| 1.1 years | 1.9 years | |
| 24.1% | 10.8% | |
| 2.0% | 1.1% |
How we compare
Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.
More comparisons: 3M vs Trane Technologies · 3M vs Boston Scientific · 3M vs Cintas · 3M vs Fastenal · Stryker vs Merck & · Stryker vs Roche · Stryker vs Thermo Fisher Scientific · Stryker vs UnitedHealth

